AGM/EGMMay 7, 2026, 04:39 PM
Pediatrix Shareholders Approve Incentive Plan with 8M New Shares
AI Summary
Pediatrix Medical Group, Inc. held its 2026 Annual Shareholders' Meeting, where shareholders approved all proposals. Key approvals included the election of all nominated directors, the ratification of PricewaterhouseCoopers LLP as the independent auditor, and the non-binding advisory approval of executive officer compensation. Most significantly, shareholders approved the Second Amended and Restated 2008 Incentive Compensation Plan, which increases the number of shares available for issuance under the plan by 8,000,000.
Key Highlights
- Shareholders approved the Second Amended and Restated 2008 Incentive Compensation Plan.
- The plan increases the number of shares available for issuance by 8,000,000.
- All nine nominated directors were elected to the Company's Board of Directors.
- PricewaterhouseCoopers LLP was ratified as the independent registered public accounting firm for 2026.
- Shareholders approved, on an advisory basis, the compensation of named executive officers for 2025.
- 77,330,139 shares were represented at the meeting, constituting a quorum.
- The incentive plan was approved with 65,912,243 votes for and 6,303,675 votes against.
Price Impact
More from MD